arrow
Y

Yassmin Moatasim

National Research Centre
H指数:29
被引数:2,459

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021–2023

埃及2021–2023年分离的高致病性禽流感病毒A(H5N1)的遗传特征与致病机理

Viruses
IF3.5
2026-03-030
OAAI
Antiviral activity of Hellenia speciosa (J. Koenig) S.R. Dutta rhizome metabolites against human adenovirus: insights from molecular docking and in vitro studies

Hellenia speciosa (J. Koenig) S.R. Dutta根状茎代谢物对人类腺病毒的抗病毒活性:分子对接和体外研究的见解

2026-01-150
OAAI
Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies

FDA批准的抗病毒药物的再利用:针对猴痘病毒的体外比较筛选和基于结构的计算机模拟研究

2025-12-050
OAAI
Revealing the Antiviral Activity of Certain Volatile Oils against Respiratory RNA and DNA Viruses Supported by Molecular Dynamics Analysis

揭示某些挥发性精油对呼吸道RNA和DNA病毒的抗病毒活性,并得到分子动力学分析的支持

2025-12-010
PRE
Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality

SARS-Cov-2 omicron变体与先前在埃及鉴定的SARS-Cov-2变体的比较,2020-2022: 洞察SARS-Cov-2基因组进化及其对流行病学,临床表现,疾病严重程度和死亡率的影响

2023-08-189
OAAI
Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
2023-04-2410
OAAI